The Donald Trump administration has delayed the introduction of sweeping tariffs on imported pharmaceuticals, despite President Donald Trump’s threat last week to impose a 100% levy on certain brand-name and patented drugs.

The tariffs were expected to take effect on Wednesday, but officials confirmed the plan is still under review.

“The Commerce Department continues to evaluate pharmaceutical companies’ proposals to reshore manufacturing and reduce drug prices to (Most Favored Nation) rates as they prepare pharmaceutical tariffs,” a White House official told CNN.

Is the tariff cancelled or just delayed?

The official clarified that the levies would not take effect on Wednesday — the date originally set by Donald Trump — but stressed that they remain under consideration.

The tariffs, t

See Full Page